发明申请
US20170066766A1 Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
审中-公开
环稠合的双环吡啶基衍生物作为FGFR4抑制剂
- 专利标题： Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- 专利标题（中）： 环稠合的双环吡啶基衍生物作为FGFR4抑制剂
-
申请号： US15357195申请日： 2016-11-21
-
公开(公告)号： US20170066766A1公开(公告)日： 2017-03-09
- 发明人: Nicole Buschmann , Robin Alec Fairhurst , Pascal Furet , Thomas Knöpfel , Catherine Leblanc , Lv Liao , Robert Mah , Pierre Nimsgern , Sebastien Ripoche , Jing Xiong , Bo Han , Can Wang , Xianglin Zhao
- 申请人： Nicole Buschmann , Robin Alec Fairhurst , Pascal Furet , Thomas Knöpfel , Catherine Leblanc , Lv Liao , Robert Mah , Pierre Nimsgern , Sebastien Ripoche , Jing Xiong , Bo Han , Can Wang , Xianglin Zhao
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 优先权： CNPCTCN2013086003 20131025; CNPCTCN2014088094 20141003
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D519/00 ; C07D498/04
摘要：
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
公开/授权文献
- US09896449B2 Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors 公开/授权日：2018-02-20
信息查询
